The development of therapeutic nanoparticles (TNPs) for cancer treatment is one of the
fastest growing research areas in oncology. Accumulating evidence has shown many …

Cancer nanotherapeutics are rapidly progressing and are being implemented to solve
several limitations of conventional drug delivery systems such as nonspecific biodistribution …

Abstract..................................................................................................... 581 17.1
Introduction.................................................................................... 582 17.2 NPs in Cancer Therapy …

Enhancing treatment techniques against cancer is highly promising due to the rapid
advancement of nanotechnology in the invention of nanomedicine agents. The recently …

Many anti-cancer drugs are poorly water-soluble and show undesirable pharmacokinetics
and low bioavailability. Nanoparticles (NP) are used as delivery vehicles to improve …

Nanoparticles have been explored as a promising drug carrier for chemotherapy, with
several systems in various stages of commercial development. This chapter describes …

Nanoparticles for cancer therapy Nanoparticles carry a big promise in oncology, for
diagnosis/imaging, therapy, or both (theragnostics). As common in medical history, there is a …

Over the past ten years, more than a billion dollars in US government funding has been
awarded to the development of nanomaterials for clinical diagnosis and therapy. In this …

Despite decades of research, progress in cancer chemotherapy is relatively slow,
hampered, in part, by the lack of appropriate mechanisms to deliver anticancer drugs …

Rapid growth in nanoparticles (NPs) as delivery systems holds vast promise to promote
therapeutic approaches for cancer treatment. Presently, a diverse array of NPs with unique …